We’re going to tariff our pharmaceuticals, and once we do that, they are going to come rushing back into our country," ...

Results from Phase II studies demonstrated that rilzabrutinib showed clinically meaningful outcomes in patients with warm ...

Results from the Phase III SPACE trial show that Ajovy significantly reduced monthly migraines in pediatric patients between ...

Family caregivers with both children and elderly family members to care for are reporting higher levels of burnout and mental ...

Amy Hessels, vice president of marketing, Bayer, discusses how its Your Decision campaign tackles misinformation about reproductive health by providing the information to empower women to discuss ...

LaShell Robinson, head of global feasibility and trial equity at Takeda, talks about Takeda's aims to expand its efforts globally by adapting strategies to regional needs.

ProFuse Technology is a company focused on the development of muscle tissue in laboratory settings. The company recently ...

Enrollment for the Phase II trial follows FDA clearance of SPG302 Investigational New Drug application for schizophrenia.

LaShell Robinson, head of global feasibility and trial equity at Takeda, discusses strategies to address underrepresentation in clinical trials, particularly in phase III psoriasis trials.

Marcel Botha, CEO of 10XBeta, discusses lessons from The Spiro Wave project that can be applied in creating more agile and ...

End-to-end automation could offer significant benefits: speed, accuracy, and scalability. Digital workers perform repetitive ...

Approval was based on results from the Phase III ALIGN study, which demonstrated a significant reduction in proteinuria at 36 ...